SCHEMBL553653

SCHEMBL553653

CC1(C)OB(c2cccc(CNC(=O)C3CCC3)c2)OC1(C)C

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
HPGD P15428 3/20 0.54
USP2 O75604 1/20 0.54
ERCC1 P07992 1/20 0.47
ERCC4 Q92889 1/20 0.47
LIPG Q9Y5X9 2/20 0.46
LPL P06858 1/20 0.46
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PKM P14618 2/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
WDR5 P61964 1/20 0.41
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL552268 0.98 ALDH1A1 (0.51) ALDH1A1HPGDUSP2ERCC1ERCC4
SCHEMBL553260 0.95 LIPG (0.48) ALDH1A1HPGDUSP2ERCC1ERCC4
SCHEMBL552918 0.87 NPSR1 (0.48) ALDH1A1MEN1KMT2APKM
SCHEMBL171732 0.81 LIPG (0.53) ALDH1A1HPGDLIPGLPLKMT2A
SCHEMBL12523750 0.81 LIPG (0.53) ALDH1A1HPGDLIPGLPLMEN1
SCHEMBL13221145 0.80 F2 (0.42) ALDH1A1USP2LIPGLPLMEN1
SCHEMBL3212986 0.80 CA1 (0.54) ALDH1A1HPGDUSP2ERCC1ERCC4
SCHEMBL16150945 0.80 NPSR1 (0.54) ALDH1A1HPGDUSP2HSD17B10
SCHEMBL23732881 0.79 LIPG (0.51) ALDH1A1HPGDLIPGLPL
SCHEMBL3189084 0.79 LIPG (0.54) ALDH1A1HPGDLIPGLPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8354406-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2013-01-15 US disclosed
US-20120035164-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2012-02-09 US disclosed
US-8063071-B2 Chemical compounds GlaxoSmithKline, LLC (US) 2011-11-22 US disclosed
US-20090143372-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC 2009-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035164-A1 CHEMICAL COMPOUNDS IKBKG, NFKBIA, RELA ALDH1A1 2634/4885HPGD 1795/4885USP2 110/4885
US-20090143372-A1 CHEMICAL COMPOUNDS IKBKG, NFKBIA, RELA ALDH1A1 2634/4885HPGD 1795/4885USP2 110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.